WALTHAM, MA -- (MARKET WIRE) -- April 11, 2007 -- EyeGate Pharma, a privately held, specialty pharmaceutical company pioneering the use of iontophoresis technology to safely and non-invasively deliver therapeutics for ocular indications, today announced that Gary P. Cook, Ph.D., Senior Director, Chemistry and Drug Delivery, will make a podium presentation at IBC’s 4th International Conference on Ocular Anti-Angiogenesis. Dr. Cook’s presentation, titled “Ocular Drug Delivery: An Alternative to a Poke in the Eye,” will take place on Monday, April 16, 2007 at 4:15 PM, at the Royal Sonesta Hotel Boston in Cambridge, MA.
